RSVpreF safe, effective for preventing respiratory syncytial virus illness in seniors
Apr 10, 2023
The findings seen in phase 3 trial of adults aged 60 years and older receiving a single intramuscular injection of RSVpreF vaccine.
FDA panel backs second RSV vaccine for older Americans
Mar 02, 2023
In a two-part vote, the panel voted 10-to-2 in favor of the vaccine’s safety and unanimously on the shot’s effectiveness.
FDA panel backs Pfizer RSV vaccine for older Americans
Mar 01, 2023
Pfizer has reported that its vaccine would reduce risk from RSV by as much as 86%.
Single dose of RSV vaccine prevents acute respiratory infection in seniors
Feb 17, 2023
High vaccine efficacy was seen against RSV A and B subtypes, across age groups among those aged 60 years and older, and for those with coexisting conditions.
Ad26.RSV.preF-RSV preF protein vaccine immunogenic in seniors
Feb 16, 2023
Vaccination results in lower RSV-mediated lower respiratory tract disease meeting one of three definitions.
Recommended 2023 adult immunization schedule published
Feb 10, 2023
Changes include a new section relating to COVID-19 vaccines and the addition of a newly licensed vaccine for hepatitis B.
Republicans coming again for healthcare worker vaccine mandate
By
Jessica R. Towhey
Jan 31, 2023
The Republican-controlled US House of Representatives is expected to vote on two bills today that would have significant effects for long-term care providers.
Ruling strikes down vaccination mandate, but industry experts say it won’t help with hiring
By
Kimberly Bonvissuto
Jan 30, 2023
A New York court ruling striking down the state’s COVID-19 vaccination mandate for healthcare workers won’t have much of an impact on senior living providers who continue to face a workforce crisis,...
More news for Friday, Jan. 27
By
Kimberly Bonvissuto
Jan 27, 2023
Headwinds may stall CCRC recovery, Fitch Ratings says … Turnover rates among assisted living staff hold steady for most operators: report … FDA advisory committee votes on proposed COVID-19 vaccine...
Overall increase seen in COVID-19 vaccine acceptance globally
Jan 11, 2023
Vaccine hesitancy varied considerably; 12.1% of vaccinated individuals were hesitant about booster doses.